Glaukos ( (GKOS)) has issued an update. Glaukos Corporation released an investor presentation in March 2026 outlining its strategy to transform glaucoma and keratoconus care through interventional, ...

BENGALURU: As Bengaluru turns pink with blooming rosy trumpet trees, ophthalmologists are reporting a sharp rise in allergic ...

Please provide your email address to receive an email when new articles are posted on . TriNetX data showed significantly increased risk for keratoconus and corneal erosion in patients with allergic ...

For patients aged 5 to 25 years, allergic conjunctivitis is associated with an increased risk for keratoconus and increased corneal diagnostic procedures, according to a study published in the ...

A new study published in the journal of Contact Lens & Anterior Eye showed that the risk of keratoconus and corneal erosion is considerably higher in individuals with allergic ...

The FDA accepted a New Drug Application with Priority Review for brepocitinib, an oral TYK2/JAK1 inhibitor, for the treatment of dermatomyositis.

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

The FDA announced a new approved use for the drug leucovorin, which Trump has touted as a treatment for autism. But the ...

In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses 5-year data on pegcetacoplan, from Apellis, for geographic atrophy.“This presentation really supported the notion that ...

The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say they ...

One person’s recreational drug trip might be another’s mental health boost. Research out today finds that dimethyltryptamine, better known as DMT, could be effective at treating people’s depression.